Company page

Genfleet Therapeutics (shanghai), Inc. Class H

Genfleet Therapeutics (Shanghai), Inc. Class H, trading under the ticker 2595 on the Hong Kong market, has a market capitalization of approximately HKD 1.38 billion. The company focuses on developing innovative therapies in the biotechnology sector. Its strategic initiatives aim to advance healthcare solutions and address unmet medical needs.